CBSC (Cardiac Biotech Solutions) Accounts Payable & Accrued Expense : $0.90 Mil (As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is Cardiac Biotech Solutions Accounts Payable & Accrued Expense?

Cardiac Biotech Solutions's quarterly accounts payable & accrued expense increased from Mar. 2024 ($0.64 Mil) to Jun. 2024 ($0.75 Mil) and increased from Jun. 2024 ($0.75 Mil) to Sep. 2024 ($0.90 Mil).

Cardiac Biotech Solutions's annual accounts payable & accrued expense increased from Mar. 2022 ($0.12 Mil) to Mar. 2023 ($0.18 Mil) and increased from Mar. 2023 ($0.18 Mil) to Mar. 2024 ($0.64 Mil).

Cardiac Biotech Solutions Accounts Payable & Accrued Expense Historical Data

The historical data trend for Cardiac Biotech Solutions's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardiac Biotech Solutions Accounts Payable & Accrued Expense Chart

Cardiac Biotech Solutions Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Accounts Payable & Accrued Expense

0.11

0.12

0.18

0.64

Cardiac Biotech Solutions Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial										0.43	0.79	0.64	0.75	0.90

Cardiac Biotech Solutions Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Cardiac Biotech Solutions Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cardiac Biotech Solutions Inc (OTCPK:CBSC) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

10845 Griffith Peak Drive, Suite 200, Las Vegas, NV, USA, 89135

Website

https://www.cbscientificinc.com

CB Scientific Inc through its U.S. and international subsidiaries provides products and services in the ambulatory non-invasive cardiac monitoring space. The FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.